Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new law prohibiting drugmaker 340B contract pharmacy restrictions takes effect tomorrow, and the drug industry has responded with more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court has dismissed AIDS Healthcare Foundation’s (AHF’s) lawsuit alleging Apexus, the 340B prime vendor, failed to negotiate [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Trade groups representing pharmacists and 340B health systems have jointly released model state legislation that would prohibit drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...] …
